My Florida Marketplace #EXP2696

Florida DOH seeks Illumina sequencing reagents and laboratory services

The Florida Department of Health’s public health laboratories seek Illumina sequencing-system supplies and support for disease surveillance and testing. - Government buyer: Florida Department of Health (DOH), Bureau of Public Health Laboratories (BPHL), Tallahassee, Florida; contact: Keshauna Johnson. - OEM: Illumina, Inc. The agency identifies Illumina as the sole manufacturer and distributor of the requested system reagents and services. - Products requested: Reagents for the Illumina MiSeq, iSeq, and NextSeq systems; quantities and part numbers are not provided. - Services requested: Services for the MiSeq, iSeq, and NextSeq systems, plus laboratory analyzer maintenance; specific quantities and part numbers are not provided. - Purpose and requirements: Support nucleic-acid sequencing, outbreak detection, and CDC-required testing for enteric and viral diseases. The notice describes Illumina kits as the only CDC-approved kits for testing SARS-CoV-2, HIV, hepatitis A, tuberculosis, and foodborne pathogens. - Term and estimated value: Three years; estimated value is $4,258,653.30. Specific start and end dates are not stated.

Description

The Florida Department of Health's Bureau of Public Health Laboratories seeks Illumina MiSeq, iSeq, and NextSeq system reagents and services for identifying nucleic acid sequences. The supplies and services support outbreak detection for enteric and viral diseases and testing required by the CDC. The intended single-source purchase is from Illumina, Inc., for a three-year term. The attachment lists an estimated dollar amount of $4,258,653.30.

View original listing